{"pmid":32442619,"title":"Thoracic Surgical Oncology in Lombardy: How to Do It During COVID-19 Time?","text":["Thoracic Surgical Oncology in Lombardy: How to Do It During COVID-19 Time?","Ann Thorac Surg","Bertolaccini, Luca","Spaggiari, Lorenzo","32442619"],"journal":"Ann Thorac Surg","authors":["Bertolaccini, Luca","Spaggiari, Lorenzo"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442619","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.athoracsur.2020.05.008","locations":["Thoracic"],"topics":["Prevention"],"weight":1,"_version_":1667535119553921024,"score":9.490897,"similar":[{"pmid":32420073,"pmcid":"PMC7225133","title":"Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.","text":["Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.","Since December, 2019, a 2019 novel coronavirus disease (COVID-19) infected by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, and the epidemic situation has continued to spread globally. The epidemic spread of COVID-19 has brought great challenges to the clinical practice of thoracic oncology. Outpatient clinics need to strengthen the differential diagnosis of initial symptoms, pulmonary ground-glass opacity (GGO), consolidation, interstitial and/or interlobular septal thickening, and crazy paving appearance. In the routine of oncology, the differential diagnosis of adverse events from COVID-19 is also significant, including radiation pneumonitis, checkpoint inhibitor pneumonitis (CIP), neutropenic fever, and so on. During the epidemic, indications of transbronchial biopsy (TBB) and CT-guided percutaneous thoracic biopsy are strictly controlled. For patients who are planning to undergo biopsy operation, screening to exclude the possibility of COVID-19 should be carried out. For confirmed or suspected patients, three-level protection should be performed during the operation. Disinfection and isolation measures should be strictly carried out during the operation. At last, more attention to the protection of cancer patients and give priority to the treatment of infected cancer patients.","Transl Lung Cancer Res","Guo, Haoyue","Chen, Xiaoxia","Su, Chunxia","Liu, Yu","Wang, Hao","Sun, Chenglong","Chen, Peixin","Jiang, Minlin","Xu, Yi","Wu, Shengyu","Jia, Keyi","Zhao, Sha","Li, Wei","Chen, Bin","Wang, Lei","Yu, Jia","Xiong, Anwen","Gao, Guanghui","Wu, Fengying","Li, Jiayu","Ye, Lingyun","Bo, Bing","Chen, Shen","Ren, Shengxiang","He, Yayi","Zhou, Caicun","32420073"],"abstract":["Since December, 2019, a 2019 novel coronavirus disease (COVID-19) infected by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, and the epidemic situation has continued to spread globally. The epidemic spread of COVID-19 has brought great challenges to the clinical practice of thoracic oncology. Outpatient clinics need to strengthen the differential diagnosis of initial symptoms, pulmonary ground-glass opacity (GGO), consolidation, interstitial and/or interlobular septal thickening, and crazy paving appearance. In the routine of oncology, the differential diagnosis of adverse events from COVID-19 is also significant, including radiation pneumonitis, checkpoint inhibitor pneumonitis (CIP), neutropenic fever, and so on. During the epidemic, indications of transbronchial biopsy (TBB) and CT-guided percutaneous thoracic biopsy are strictly controlled. For patients who are planning to undergo biopsy operation, screening to exclude the possibility of COVID-19 should be carried out. For confirmed or suspected patients, three-level protection should be performed during the operation. Disinfection and isolation measures should be strictly carried out during the operation. At last, more attention to the protection of cancer patients and give priority to the treatment of infected cancer patients."],"journal":"Transl Lung Cancer Res","authors":["Guo, Haoyue","Chen, Xiaoxia","Su, Chunxia","Liu, Yu","Wang, Hao","Sun, Chenglong","Chen, Peixin","Jiang, Minlin","Xu, Yi","Wu, Shengyu","Jia, Keyi","Zhao, Sha","Li, Wei","Chen, Bin","Wang, Lei","Yu, Jia","Xiong, Anwen","Gao, Guanghui","Wu, Fengying","Li, Jiayu","Ye, Lingyun","Bo, Bing","Chen, Shen","Ren, Shengxiang","He, Yayi","Zhou, Caicun"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420073","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.21037/tlcr.2020.02.10","keywords":["2019 novel coronavirus disease (covid-19)","severe acute respiratory syndrome corona virus 2 (sars-cov-2)","thoracic oncology"],"locations":["Wuhan","Hubei","thoracic","thoracic","thoracic"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667254896752066560,"score":45.938576},{"pmid":32497294,"title":"Surgical oncology at the time of COVID-19 outbreak.","text":["Surgical oncology at the time of COVID-19 outbreak.","J Surg Oncol","Bogani, Giorgio","Signorelli, Mauro","Ditto, Antonino","Raspagliesi, Francesco","32497294"],"journal":"J Surg Oncol","authors":["Bogani, Giorgio","Signorelli, Mauro","Ditto, Antonino","Raspagliesi, Francesco"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32497294","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jso.25975","topics":["Prevention"],"weight":1,"_version_":1668712823951196160,"score":45.373222}]}